Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKiniksa Pharmaceuticals International Plc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | $0.15 | $0.24 | $0.20 |
| Q2 2026 | 3 | $0.29 | $0.31 | $0.30 |
| Q3 2026 | 3 | $0.28 | $0.49 | $0.36 |
| Q4 2026 | 3 | $0.22 | $0.61 | $0.39 |
| Q1 2027 | 1 | $0.39 | $0.41 | $0.40 |
| Q2 2027 | 1 | $0.46 | $0.49 | $0.48 |
| Q3 2027 | 1 | $0.52 | $0.56 | $0.54 |
| Q4 2027 | 1 | $0.60 | $0.64 | $0.62 |
Kiniksa Pharmaceuticals International Plc. Earnings Date And Information
Kiniksa Pharmaceuticals International Plc. last posted its earnings results on Tuesday, July 28th, 2026. The company reported $0.3 earnings per share for the quarter, topping analysts' consensus estimates of $0.2995 by $0.0005. The company had revenue of 243.60 M for the quarter and had revenue of 677.56 M for the year. Kiniksa Pharmaceuticals International Plc. has generated $1 earnings per share over the last year ($0.75 diluted earnings per share) and currently has a price-to-earnings ratio of 70.92. Kiniksa Pharmaceuticals International Plc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Kiniksa Pharmaceuticals International Plc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/28/2026 | Q2 2026 | $0.30 | $0.33 | 0.03 | $226.49 M | $243.60 M |
| 04/28/2026 | Q1 2026 | $0.18 | $0.30 | 0.12 | $206.11 M | $214.27 M |
| 02/24/2026 | Q4 2025 | $0.29 | $0.19 | -0.1 | $200.81 M | $202.13 M |
| 10/28/2025 | Q3 2025 | $0.33 | $0.25 | -0.08 | $167.39 M | $180.86 M |
| 07/29/2025 | Q2 2025 | $0.18 | $0.24 | 0.06 | $146.48 M | $156.80 M |
| 04/29/2025 | Q1 2025 | $0.02 | $0.12 | 0.1 | $131.88 M | $137.79 M |
| 02/25/2025 | Q4 2024 | -$0.06 | -$0.12 | -0.06 | $123.42 M | $122.54 M |
| 10/29/2024 | Q3 2024 | -$0.02 | -$0.18 | -0.16 | $111.51 M | $112.21 M |
| 07/25/2024 | Q2 2024 | N/A | -$0.06 | N/A | $90.60 M | $108.63 M |
| 04/25/2024 | Q1 2024 | N/A | -$0.25 | N/A | N/A | $79.86 M |
| 02/28/2024 | Q4 2023 | -$0.11 | $0.36 | 0.47 | N/A | $83.40 M |
| 11/02/2023 | Q3 2023 | N/A | -$0.20 | N/A | $64.55 M | $67.05 M |
| 08/01/2023 | Q2 2023 | N/A | $0.21 | N/A | $52.06 M | $71.47 M |
| 05/04/2023 | Q1 2023 | N/A | -$0.18 | N/A | N/A | $48.35 M |
| 03/02/2023 | Q4 2022 | N/A | $0.06 | N/A | N/A | $61.88 M |
| 11/03/2022 | Q3 2022 | N/A | $3.23 | N/A | $93.58 M | $99.14 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.29 | N/A | $28.42 M | $26.97 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.36 | N/A | N/A | $32.19 M |
| 02/24/2022 | Q4 2021 | N/A | -$0.53 | N/A | N/A | $18.75 M |
| 11/04/2021 | Q3 2021 | N/A | -$0.44 | N/A | $10.26 M | $12.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kiniksa Pharmaceuticals International Plc. Earnings: FAQ's
In the previous quarter, Kiniksa Pharmaceuticals International Plc. (:KNSA) reported $0.3 earnings per share (EPS) to beat the analysts' consensus estimate of $0.2995 by $0.0005.
The conference call for Kiniksa Pharmaceuticals International Plc.'s latest earnings report can be listened to online.
The conference call transcript for Kiniksa Pharmaceuticals International Plc.'s latest earnings report can be read online.
Kiniksa Pharmaceuticals International Plc. (:KNSA) has a recorded annual revenue of $677.56 M.
Kiniksa Pharmaceuticals International Plc. (:KNSA) has a recorded net income of $59.01 M.Kiniksa Pharmaceuticals International Plc. has generated $0.8 earnings per share over the last four quarters.
Kiniksa Pharmaceuticals International Plc. (:KNSA) has a price-to-earnings ratio of 70.92 and price/earnings-to-growth ratio is 0.04.